Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

111
Actual shortage: 2 (2%)
Anticipated shortage: 1 (1%)
Avoided shortage: 5 (5%)
Resolved: 103 (93%)

Discontinuation Reports

9
To be discontinued: 0 (0%)
Discontinued: 8 (89%)
Reversed: 1 (11%)

Late reports

3 (3%)

Overdue reports

2 (67%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VIIBRYD 10MG TABLET Resolved 2019-01-15 2019-02-28 72344
CONSTELLA 290MCG CAPSULE Resolved 2019-02-19 2019-02-27 76263
BYSTOLIC 10.0MG TABLET Resolved 2019-01-29 2019-02-22 73787
ACULAR 0.5% SOLUTION Resolved 2018-11-06 2019-02-21 66328
BELKYRA 10MG SOLUTION Resolved 2018-11-01 2019-02-16 65967
BYSTOLIC 5.0MG TABLET Resolved 2018-12-05 2019-02-08 68675
ALPHAGAN P 0.15% SOLUTION Resolved 2019-01-21 2019-01-23 73016
CONSTELLA 290MCG CAPSULE Resolved 2018-11-20 2019-01-09 67153
ACUVAIL 0.45% SOLUTION Resolved 2018-10-09 2018-10-19 63456
SURVANTA 25MG SUSPENSION Resolved 2018-07-27 2018-08-30 56829
ZYMAR 0.3% SOLUTION Resolved 2017-08-03 2017-10-13 18241

Showing 101 to 111 of 111

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835

Showing 1 to 9 of 9